Cell Source, Inc.

Biotechnology • Healthcare • New York, NY, United States • CLCS (PNK)

Cell Source, Inc., a biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance. Its lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. The company's Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease; other non-malignant organ diseases through organ transplantation; and various cancers and non-malignant diseases. Cell Source, Inc. is headquartered in New York, New York.

646 416 7896 57 West 57th Street, New York, NY 10019, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Beam Therapeutics stock rises on promising sickle cell therapy data - Investing.com

Investing.com • Dec 8

7 Hydrogen Stocks to Watch in 2025 - The Motley Fool

The Motley Fool • Dec 10

Bloom Energy’s stock is up 1,000% in a year because its fuel cells are solving AI’s data center power problem - Fortune

Fortune • Oct 16

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant

BioInformant • Oct 17

Global mobile traffic 2025 - Statista

Statista • Nov 19

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Cell Source, Inc. had layoffs?

No layoff events have been recorded for Cell Source, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Cell Source, Inc. have?

Cell Source, Inc. has approximately 1 employees.

What industry is Cell Source, Inc. in?

Cell Source, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Cell Source, Inc. a publicly traded company?

Yes, Cell Source, Inc. is publicly traded under the ticker symbol CLCS on the PNK. The company has a market capitalization of approximately $0.02 billion.

Where is Cell Source, Inc. headquartered?

Cell Source, Inc. is headquartered in New York, NY, United States at 57 West 57th Street, New York, NY 10019, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.